BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31020747)

  • 21. Prospective study of cryopreserved placental tissue wound matrix in the management of chronic venous leg ulcers.
    Farivar BS; Toursavadkohi S; Monahan TS; Sharma J; Ucuzian AA; Kundi R; Sarkar R; Lal BK
    J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):228-233. PubMed ID: 30621916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers.
    Jaschke E; Zabernigg A; Gattringer C
    Int J Dermatol; 1999 May; 38(5):380-6. PubMed ID: 10369552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The bacteriology of chronic venous ulcers treated with occlusive hydrocolloid dressings.
    Gilchrist B; Reed C
    Br J Dermatol; 1989 Sep; 121(3):337-44. PubMed ID: 2803959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized, double-blind, placebo-controlled, dose- ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers.
    Da Costa RM; Ribeiro Jesus FM; Aniceto C; Mendes M
    Wound Repair Regen; 1999; 7(1):17-25. PubMed ID: 10231502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine and protease levels in healing and non-healing chronic venous leg ulcers.
    Harris IR; Yee KC; Walters CE; Cunliffe WJ; Kearney JN; Wood EJ; Ingham E
    Exp Dermatol; 1995 Dec; 4(6):342-9. PubMed ID: 8608341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of proteases as prognostic markers for the healing of venous leg ulcers.
    Hoffman R; Noble J; Eagle M
    J Wound Care; 1999 Jun; 8(6):273-6. PubMed ID: 10776209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers.
    Trengove NJ; Bielefeldt-Ohmann H; Stacey MC
    Wound Repair Regen; 2000; 8(1):13-25. PubMed ID: 10760211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin.
    Serra R; Buffone G; Falcone D; Molinari V; Scaramuzzino M; Gallelli L; de Franciscis S
    Wound Repair Regen; 2013; 21(3):395-401. PubMed ID: 23531093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
    Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrasting host immuno-inflammatory responses to bacterial challenge within venous and diabetic ulcers.
    McInnes RL; Cullen BM; Hill KE; Price PE; Harding KG; Thomas DW; Stephens P; Moseley R
    Wound Repair Regen; 2014; 22(1):58-69. PubMed ID: 24354589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can Wound Exudate from Venous Leg Ulcers Measure Wound Pain Status?: A Pilot Study.
    Goto T; Tamai N; Nakagami G; Kitamura A; Naito A; Hirokawa M; Shimokawa C; Takahashi K; Umemoto J; Sanada H
    PLoS One; 2016; 11(12):e0167478. PubMed ID: 27936243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing venous stasis disease and ulcers.
    Thomas DR
    Clin Geriatr Med; 2013 May; 29(2):415-24. PubMed ID: 23571036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ulcer area reduction at 2 weeks predicts failure to heal by 24 weeks in the venous leg ulcers of patients living alone.
    Parker CN; Finlayson KJ; Edwards HE
    J Wound Care; 2016 Nov; 25(11):626-634. PubMed ID: 27827277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicentre study of percentage change in venous leg ulcer area as a prognostic index of healing at 24 weeks.
    Kantor J; Margolis DJ
    Br J Dermatol; 2000 May; 142(5):960-4. PubMed ID: 10809855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of hyperbaric oxygen therapy for healing chronic venous leg ulcers: A randomized, double-blind, placebo-controlled trial.
    Thistlethwaite KR; Finlayson KJ; Cooper PD; Brown B; Bennett MH; Kay G; O'Reilly MT; Edwards HE
    Wound Repair Regen; 2018 Jul; 26(4):324-331. PubMed ID: 30129080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wound care in venous ulcers.
    Mosti G
    Phlebology; 2013 Mar; 28 Suppl 1():79-85. PubMed ID: 23482540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infrared thermography to prognose the venous leg ulcer healing process-preliminary results of a 12-week, prospective observational study.
    Cwajda-Białasik J; Mościcka P; Jawień A; Szewczyk MT
    Wound Repair Regen; 2020 Mar; 28(2):224-233. PubMed ID: 31705776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healing rate and bacterial necrotizing vasculitis in venous leg ulcers.
    Piérard-Franchimont C; Paquet P; Arrese JE; Piérard GE
    Dermatology; 1997; 194(4):383-7. PubMed ID: 9252771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds.
    Loots MA; Lamme EN; Zeegelaar J; Mekkes JR; Bos JD; Middelkoop E
    J Invest Dermatol; 1998 Nov; 111(5):850-7. PubMed ID: 9804349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors related to the failure of venous leg ulcers to heal with compression treatment.
    Milic DJ; Zivic SS; Bogdanovic DC; Karanovic ND; Golubovic ZV
    J Vasc Surg; 2009 May; 49(5):1242-7. PubMed ID: 19233601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.